MJNA (Medical Marijuana) Net Income: $-148.11 Mil (TTM As of Dec. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medical Marijuana Net Income?

Medical Marijuana MJNA +100.00% Net Income is $-148.11 Mil as of Dec. 2017.

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Medical Marijuana's Net Income for the six months ended in Dec. 2017 was $-148.11 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2017 was $-148.11 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Medical Marijuana's Earnings per Share (Diluted) for the six months ended in Dec. 2017 was $-0.05.


Medical Marijuana  (OTCPK:MJNA) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Medical Marijuana's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Medical Marijuana Net Income Related Terms


Medical Marijuana Net Income Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana Net Income Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Income
Get a 7-Day Free Trial 24.61 -4.49 25.97 -25.91 -148.11

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Income Get a 7-Day Free Trial 24.61 -4.49 25.97 -25.91 -148.11

Medical Marijuana Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Medical Marijuana's Net Income for the fiscal year that ended in Dec. 2017 is calculated as

Net Income(A: Dec. 2017 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-142.198+0+-5.906+-0.00099999999997635
=-148.11

Medical Marijuana's Net Income for the quarter that ended in Dec. 2017 is calculated as

Net Income(Q: Dec. 2017 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-142.198+0+-5.906+-0.00099999999997635
=-148.11

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income for the trailing twelve months (TTM) ended in Dec. 2017 was $-148.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Income →
What does a Net Income of $-148.11 Mil mean?
Medical Marijuana (MJNA) has a Net Income of $-148.11 Mil as of Dec. 2017. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Medical Marijuana and its competitors.
Is Medical Marijuana's Net Income too high?
Medical Marijuana's current Net Income is $-148.11 Mil.
How does Medical Marijuana's Net Income compare to UPC and ERBB?
Medical Marijuana's Net Income of $-148.11 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income for a Drug Manufacturers company?
A good Net Income depends on the Drug Manufacturers industry context. However, Net Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income mean?
A high Net Income can signal that a stock is expensive relative to its fundamentals. Net Income is the total earnings after all operating expenses, interest and taxes. View historical data on Medical Marijuana and its competitors. Medical Marijuana's current Net Income is $-148.11 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current Net Income of $-148.11 Mil. The current Net Income is $-148.11 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income calculated?
Net Income is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current Net Income is $-148.11 Mil as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.